🇯🇵 Nubeqa in Japan

PMDA authorised Nubeqa on 23 January 2020

Marketing authorisation

PMDA — authorised 23 January 2020

  • Marketing authorisation holder: Bayer Yakuhin, Ltd
  • Status: approved

Nubeqa in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Japan

Frequently asked questions

Is Nubeqa approved in Japan?

Yes. PMDA authorised it on 23 January 2020.

Who is the marketing authorisation holder for Nubeqa in Japan?

Bayer Yakuhin, Ltd holds the Japanese marketing authorisation.